Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
Background: Metabolic syndrome (MS) is a global epidemic that has great socioeconomic and public health implications. This study reports observed effects of the Shexiang Baoxin Pill (SBP) in a rat model of MS and explores its underlying mechanisms of action.Methods: A diet-induced rat model of MS wa...
Main Authors: | Dan Wei, Ningning Zheng, Lanyan Zheng, Leting Wang, Liang Song, Luning Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00137/full |
Similar Items
-
Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow
by: Hongxin Guo, et al.
Published: (2022-08-01) -
Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting Strategy
by: Liu-qing Yang, et al.
Published: (2019-05-01) -
Exploring the pathways and targets of Shexiang Baoxin pill for coronary heart disease through a network pharmacology approach
by: Shou-De Zhang, et al.
Published: (2018-01-01) -
Shexiang Baoxin Pill, a Traditional Chinese Herbal Formula, Rescues the Cognitive Impairments in APP/PS1 Transgenic Mice
by: Wei-Hui Hu, et al.
Published: (2020-07-01) -
Protective Effect of Shexiang Baoxin Pill on Myocardial Ischemia/Reperfusion Injury in Patients With STEMI
by: Haixia Qin, et al.
Published: (2021-09-01)